Previous studies showed that the TGF-β signaling pathway regulates collagen deposition (10, 22); thus, we assessed the key downstream proteins (Smad2, Smad3, Smad4, and COL1A1) in this signaling pathway in normal colon tissue and tumors from CRC patients. The gene discussed is COL1A1; the disease is colorectal carcinoma.